ScheBo®• Company News
ScheBo®• SARS-CoV-2 Quick™ IgM/IgG 2in1 combined rapid test
ScheBo Biotech engineered her own rapid test for the detection of SARS-CoV-2 IgM and IgG antibodies from human whole blood, serum and plasma samples.
» link to the product
The Fecal M2-PK As A Novel Biomarker for Screening of Cancer Colon
Scientists from Egypt present a new study for the use of M2-PK as a biomarker for screening of colorectal cancer in ‚The Egyptian Journal of Community Medicine’ July-2018.
Mohamed El–Tantawy Ibrahim et al.:
The Fecal M2-PK As A Novel Biomarker for Screening of Cancer Colon
» link to the abstract
ScheBo®• Calprotectin Smart™ ELISA test
ScheBo Biotech engineered her own ELISA test for the quantitative determination of Lactoferrin in stool samples.
» link to the product
ScheBo®• Lactoferrin Smart™ ELISA test
ScheBo Biotech engineered her own ELISA test for the quantitative determination of Lactoferrin in stool samples.
» link to the product
Pancreas Elastase 1 Quick Test study published in “Journal of Cystic Fibrosis” June-2016
Polish scientists publish a study of the sensitivity and specificity of the Pancreas Elastase 1 Quick test in comparison to the ELISA test in the “Journal of Cystic Fibrosis”.
Walkowiak et al.:
Pancreatic Elastase-1 Quick Test for rapid assessment of pancreatic status in cystic fibrosis patients
» link to the abstract
Malaysian Study: Newest data on the M2-PK test published in journal „PLOS ONE“ July-2015
Suresh Sithambaram, Ida Hilmi, Khean-Lee Goh:
The Diagnostic Accuracy of the M2 Pyruvate Kinase Quick Stool Test- A Rapid Office Based Assay Test for the Detection of Colorectal Cancer
» read more
Multicenter Study: Newest data on the M2-PK test published in journal „Gut and Liver“ January-2015
Kim YC, et al.:
The Usefulness of a Novel Screening Kit for Colorectal Cancer Using the Immunochromatographic Fecal Tumor M2 Pyruvate Kinase Test
» read more
ScheBo®• Pancreas Elastase 1 Quick™ Canine test
Stool test for the fast and reliable diagnosis/ exclusion of Exocrine Pancreatic Insufficiency
… now also available as a rapid test
The new ScheBo®• Pancreas Elastase 1 Quick™ Canine is a rapid test to quickly and conveniently exclude or diagnose canine EPI in your own surgery.
» link to the product
ScheBo®• Pancreas Elastase 1 Quick™ test
Faecal Pancreatic Elastase 1
The Gold Standard for Non-Invasive Exocrine Pancreatic Function Testing
… now also available as a rapid test
The ScheBo®• Pancreas Elastase 1 Quick™ stool test is a reliable and easy to perform rapid test for the detection of Pancreatic Elastase 1 in stool samples.
» link to the product
Gastroenterology 2013, 144: 602
Sung, Joseph J. S. et al.:
The use of a new stool test M2-PK in the diganosis of colorectal cancer: A case-control study
Journal of Gastroenterology and Hepatology 2013, 28
Suresh Sithambaram Suresh et al.:
Colonic and Anorectal Disorders M2PK – A new immunochromotographic testing for colorectal carcinoma screening: Preliminary results
2in1 Colorectal Cancer Screening Test
New innovative combined rapid test to simultaneously detect the enzyme biomarker M2-PK and human haemoglobin for improved colorectal cancer screening.
The ScheBo®• 2in1 Quick™ test is a brand new colorectal cancer-screening test, which can detect colorectal cancers and polyps by simultaneously using direct (M2-PK) and indirect methods (iFOBT). An innovation, the ScheBo®• 2in1 Quick™ test is able to detect both non-bleeding and bleeding colorectal cancers and polyps.
» link to the product
World Journal of Gastroenterology, 2012 August 14; 18 (30):4004 – 4011
Tonus, Carolin; Sellinger, Markus; Koss, Konrad; Neupert, Gero:
Faecal pyruvate kinase isoenzyme type M2 for colorectal cancer screening:
A meta-analysis
» link to the publication
AEO-Certificate
The Main Customs Office of Giessen, Germany issued an AEO-F Certificate (Authorized Economic Operator – Customs Simplifications plus Security and Safety) to ScheBo Biotech AG on September 30, 2011.
ACB News, Issue 570, October 2010
Corporate News: ScheBo Biotech and M2-PK
Science 17 September 2010, Vol. 329. no. 5998, pp. 1492 – 1499
Matthew G. Vander Heiden et. al.:
Evidence for an Alternative Glycolytic Pathway in Rapidly Proliferating Cells
» link to the abstract
Biomarker ′M2-PK′ Identified as Key Enzyme in Cancer Diagnosis and Therapy
Ground Breaking Findings on Understanding Cancer Published in the Current Issue of ′Science′:
Cancer research is facing a radical change of direction. Cancer cells do not obtain their energy from the breakdown of sugar to carbon dioxide and water, but from energy-rich intermediates of sugar metabolism instead.
» link to the article
Video from the Focus 2009 meeting
Dr. David Sanders: Stool Tests Help Gastroenterologists
Focusing on results with faecal pancreatic elastase and faecal lactoferrin from clinical studies conducted at the Royal Hallamshire Hospital in Sheffield, Dr David Sanders discusses the clinical value of faecal diagnostic assays
» link to the video
Nature 452, 230-233 (13 March 2008)
Heather R. Christofk et al.:
Pyruvate kinase M2 is a phosphotyrosine-binding protein
» link to the abstract
Nature 452, 230-233 (13 March 2008)
Heather R. Christofk et al.:
The M2 splice isoform of pyruvate kinase is important for cancer metabolism and tumour growth
» link to the abstract
Castle Rauischholzhausen March 7-8, 2008
Second Giessen International Workshop on Interactions of Exocrine and Endocrine Pancreatic Diseases
Veterinary Microbiology, Volume 123, Issue 4, 31-Aug-2007, S. 336-345
Schönenbrücher, H. et al.:
Detection of central nervous system tissues in meat products: Validation and standardization of a real-time PCR-based detection system
» link to the abstract
Pharmaceutical International
Leeds, John S.; Sanders, David S.:
Coeliac disease and pancreatic exocrine insufficiency
» link to the article
Alimentary Pharmacology & Therapeutics, February 2007, Volume 25, Issue 3, S. 265-271
Leeds, John S. et al.:
Is exocrine pancreatic insufficiency in adult coeliac disease a cause of persisting symptoms?
» link to the article
British Journal of Cancer, 2007, Volume 96, S. 1329-1334
Haug, U. et al.:
Tumour M2-PK as a stool marker for colorectal cancer: comparative analysis in a large sample of unselected older adults vs colorectal cancer patients
» link to the article
European Journal of Gastroenterology & Hepatology, March 2007, 9(3), S.265-276
Kumar, Y. et al.:
Tumour M2-pyruvate kinase: a gastrointestinal cancer marker
» link to the article
World Journal of Gastroenterology 2006 November 21; 12 (43)
Tonus, C.; Neupert, G.; Sellinger, M.:
Colorectal cancer screening by non-invasive metabolic biomarker fecal tumor M2-PK
» link to the article
38th Meeting of the European Pancreatic Club (EPC), Tampere, Finland, June 7-10, 2006
Ewald, N. et al.:
Prevalence of diabetis melitus secondary to pancreatic diseases (type 3c)
13th UEGW (United European Gastroenterology Week), Copenhagen, Denmark, October 15-19, 2005
Ewald, N. et al.:
Pyruvate kinase M2 (Tumor M2-PK) as a screening tool for colorectal cancer (CRC)
NCRI Conference, Birmingham, UK, 2.-5. Oktober 2005
McLoughlin, R.M. et al.:
Tumour M2-PK, a novel screening tool for colorectal cancer
ASCO 41st Annual Meeting, Orlando, Florida, USA, 13.-17. Mai 2005
Klör, H.U. et al.:
The tumor metabolic marker Tumor M2-PK in stool: a new biomarker for colorectal cancer
Vet Clin Pathol. 2005; 34(1): 49-51
Battersby IA, Peters IR, Day MJ, German AJ, Hall EJ.:
Effect of intestinal inflammation on fecal elastase concentration in dogs
Pharmaceutical International
Smith, Ivor:
Faster and Easier ScheBo® • Biotech ′Feacal Elastase Test′
» link to the article
Clinical Advances in Hematology and Oncology, October 2004
Clinical Symposia Report: Advances in Gastrointestinal Cancer: A Report from the World GI Congress, June 16-19, 2004, Barcelona, Spain
cancerconsultants.com, Cancer News Article, 6. Oktober 2004
New Fecal Screening Test Shows Promise in Detecting Colorectal Cancer
British Journal of Cancer, Press Release, 25. August 2004
Enzyme signpost points to better colon cancer test
BBC News, 24. August 2004
′Better′ bowel cancer test found
washingtontimes.com, 24. August 2004
Germans develop new colon cancer test
Cancer Compass, 30. Juli 2004
Scientists Present A New Colorectal Cancer Test, Tumour M2-PK
Abstract from the World Congress on Gastrointestinal Cancer, June 16-19, 2004, Barcelona, Spain
Hardt, P.D., et al:
Tumor M2-PK in Stool: A Screening Tool for Colorectal Cancer